BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2001
View Archived Issues
Curis begins clinical evaluation of Vascugel in coronary artery disease
Read More
Atrix seeks FDA approval for one-month Leuprogel product
Read More
HspE7 granted orphan drug status from FDA for recurrent respiratory papillomatosis
Read More
Astra Zeneca seeks FDA approval for breast cancer treatment
Read More
Promising data reported from phase I trial of Esperion's ApoA-I Milano
Read More
Lumigan: a potent, long-acting and safe new IOP-lowering drug
Read More
Liposome-based formulation of mitoxantrone as a viable alternative to conventional drug
Read More
GPC Biotech reaches milestones in antimicrobial alliance with Byk Gulden
Read More
AACR news: novel fumagillin derivative CKD-732 as a component of combination chemotherapy
Read More
Shareholders overwhelmingly approve BioChem Pharma-Shire merger
Read More
Antiangiogenic therapies targeting both paracrine and autocrine VEGF signaling pathways
Read More
NeoTherapeutics begins phase II Parkinson's disease trial of Neotrofin
Read More
GlycoDesign expands GD-0039 clinical program
Read More
ImmunoGen and Raven to jointly develop novel antibody therapeutics for ovarian cancer
Read More
Research data on OSI-774 presented at AACR meeting
Read More
FDA grants priority review status for Entocort modified-release capsules
Read More
HGS initiates phase I trial of Albuferon as treatment for HCV
Read More
Autologous bone marrow cell implantation: a novel strategy for optimizing therapeutic angiogenesis
Read More
Raxofelast restores VEGF expression and stimulates healing, angiogenesis in diabetic mice
Read More
Design of new orally bioavailable factor Xa inhibitors reported at ACS
Read More
ACS news: A-292438 as a promising ETA-selective antagonist
Read More
DuPont R&D continues focus on potent, selective and orally active factor Xa inhibitors
Read More
Potent and selective 20-HETE synthase inhibitors under study at Taisho
Read More
New series of factor Xa inhibitors patented by Cor research group
Read More
Indole-based 5-HT2 receptor ligands described by Vernalis
Read More
Telik prepares novel glucose uptake promoters for use in type 2 diabetes
Read More
Angiogene claims compounds with the ability to damage newly formed vascular endothelium
Read More
Two new patents owned by Pharmacia cover CDK inhibitors
Read More
Nonpeptide inhibitors of VLA-4-mediated cell adhesion emerge from R&D at Biogen
Read More